We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.51 | 3.02 | 4.00 | - | 1,028 | 08:00:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.80 | 10.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/1/2023 12:17 | Wrighty, Low expectations IMHO. I am hoping for north of 30p! | goatherd | |
07/1/2023 17:55 | Thanks Colin. I’m hoping to see a jump in revenues this year from existing streams, licensing & milestone payments. I hope that this can reflect in a share price north of 6p by y/e. W41 | wrighty41 | |
07/1/2023 12:07 | Anil Padmanabhan is the Randox International Business Manager for the Middle East & South Asia He attended the ESEM (Emirates Society of Emergency Medicine) Conference at Conrad Abudhabi - UAE last month. He was on the Randox booth to show how Randox can help the emergency, ICU and Laboratory Medicine departments in Clnical Toxicology in particular help for Stroke Patients from a blood sample using our Evidence Multistat Biochip array POCT analyser. | colinhy | |
06/1/2023 21:50 | Thermo Fisher Scientific Inc (TMO) Fundamentals Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%). SHARE INFORMATION Market Cap US$ 220,382,527,389 Proteome mk cap app 11m | goggin | |
06/1/2023 16:52 | Loads for my sins. | peverill | |
06/1/2023 16:45 | I don't worry about my holding, peverill - nor yours, come to think of it. Do you actually own any? | goatherd | |
06/1/2023 16:31 | No one asked your opinion,you worry about your own holding. | peverill | |
06/1/2023 16:18 | Quite so. About 25m shares should do it. | monte1 | |
06/1/2023 16:12 | 91936 Only if you actually own enough shares Peverill - which, judging from your posts, I have my doubts about. | goatherd | |
06/1/2023 15:20 | Plenty of time for that J. | peverill | |
06/1/2023 13:58 | I can feel a "Go on, then" coming on. | jeffian | |
06/1/2023 13:22 | So,come June I should be a millionaire??? | peverill | |
06/1/2023 11:54 | Does it work then?.... I mean as good as Matron? | dominiccummings | |
06/1/2023 11:47 | Google "Stroke Blood Test" or "Blood Test For Stroke" Answer There is no blood test that can diagnose a stroke. However, in the hospital, your doctor or nurse may do a series of blood tests to learn the cause of your stroke symptoms: Complete blood count (CBC). Wasjobber is correct. Randox (& Galaxy CCRO) will be the FIRST EVER blood tests to diagnose stroke. | pools2 | |
06/1/2023 11:37 | A clue: "Worlds first Stroke blood tests" You'd all do well to do a little research yourselves, rather than trolling here all day. | wasjobber | |
06/1/2023 11:25 | #91931 A ba’ hair? | monte1 | |
06/1/2023 11:21 | #91922, Ah, the old size-of-the-market thing, eh? Haven't seen that old chestnut for a while. Has anyone worked out what percentage PRM achieved of the "£9bn+" biomarker market from the report they commissioned in around 2010? | jeffian | |
06/1/2023 10:59 | So wheres the value in PRM's AZ biomarkers if everyones at it? | elpirata | |
06/1/2023 10:01 | I have ‘heard’ of Directors rushing enraged from Board Meetings to call an avatar to complain that other anonymous avatars are wrong on the freebb. | monte1 | |
06/1/2023 09:41 | Be nice to know how random people on the street know before the Directors what's going on. | peverill | |
06/1/2023 09:24 | Because none of these ‘coming soon’ have ever actually arrived? | monte1 | |
06/1/2023 09:22 | Which could be because nobody has seen it? | dominiccummings | |
06/1/2023 09:21 | #91924 Obviously, because this company suffers from an extreme version of 'expectation fatigue'. Otherwise known as believe it when I see it. | bluemango | |
06/1/2023 09:17 | If all this is common knowledge,why are we at 3p a share.???? | peverill |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions